Midazolam hydrochloride and Mental impairment - a phase IV clinical study of FDA data
No or few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or few reports are found.
What is Midazolam Hydrochloride?
Midazolam hydrochloride has active ingredients of midazolam hydrochloride. It is used in insomnia. Currently, eHealthMe is studying from 3,199 Midazolam hydrochloride users.
What is Mental Impairment?
Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition) is found to be associated with 2,100 drugs and 1,295 conditions by eHealthMe. Currently, we are studying 26,302 people who have Mental impairment.
Do you take Midazolam hydrochloride and have Mental impairment?Check whether Mental impairment is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Midazolam hydrochloride side effects by duration, gender and age:
- Midazolam hydrochloride side effects (3,199 reports)
Mental impairment treatments and more:
- Mental impairment (26,302 reports)
All the drugs that are associated with Mental impairment:
All the conditions that are associated with Mental impairment:
How the study uses the data?
The study uses data from the FDA. It is based on midazolam hydrochloride (the active ingredients of Midazolam hydrochloride) and Midazolam hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Econazole Nitrate and Plavix drug interaction - now
- Nicotrol and Codeine drug interaction - 3 seconds ago
- Cobalamin and Mouth Ulcers - 8 seconds ago
- Ethosuximide and Unilateral Hydronephrosis - 16 seconds ago
- Stelara and Blastomycosis - 18 seconds ago
- Cipro and Emphysema - 18 seconds ago
- Flexeril and Complex Regional Pain Syndrome - 19 seconds ago
- Vitamin E and Drooling - 23 seconds ago
- Aubagio and Gout - 27 seconds ago
- Liothyronine Sodium and Drowsiness - 33 seconds ago